Paragon Biosciences – Who We Are

Paragon Biosciences is a renown healthcare development and biopharmaceutical investment firm with a global impact. Paragon helps build companies that research and test medicinal products. The company is committed to scientific research and patients. Paragon’s track record boasts 13 FDA drug approvals since their conception over a decade ago.

Paragon has experienced staff readily available to develop and fund biotech companies with their innovative drug research programs. Paragon has a host of clinical professionals that provide expert support to entrepreneurs and companies that use breakthrough technology to create medical advances. In addition to funding, the company works hand-in-hand with collaborators to develop clinical trials to perfect medicines for patients across the world.

 

The Man Behind Paragon

Jeff Aronin has been at the helm of Paragon Biosciences as its Chairman and CEO since 2010. Aronin is also affiliated with several Paragon portfolio companies and founded Ovation Pharmaceuticals Inc. and served as its President and CEO in 2000. Jeff Aronin brings with him to the company a long line of leadership and expertise in global corporation management. He also has experience with structuring and executing major transactions, mergers and acquisitions. His daily management skills are second to none and have pushed Paragon Biosciences to the top of the biopharmaceutical industry.

Jeff Aronin also has an extensive background in finance and brand marketing, which greatly aid in setting up satellite companies. He uses all his skills to create a fine-tuned business that has cutting-edge plans for development. Aronin also brings his years of experience from working within a regulatory industry; therefore, he has a library of information on government regulations regarding biopharmaceuticals. Surely Jeff Aronin and Paragon Biosciences will continue to forge forward with medical breakthroughs to aide patients across the world.